Sponsor:
GlaxoSmithKline
Code:
NCT06551142
Conditions
Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
GSK5764227
Cisplatin
Carboplatin
Atezolizumab
Pembrolizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-10. This information was provided to ClinicalTrials.gov by GlaxoSmithKline on 2025-10-14.